Alternative Names
Anti-BAFF MAb research-grade biosimilar; Anti-BAFF monoclonal antibody research-grade biosimilar; LY 2127399 research-grade biosimilar; LY-2127399 research-grade biosimilar; Tabalumab (genetical recombination) (JAN) research-grade biosimilar; Tabalumab (USAN) research-grade biosimilar; TNFSF13B antibody; BAFF antibody; BLYS antibody; TALL1 antibody; TNFSF20 antibody; ZTNF4 antibody; UNQ401/PRO738 antibody;Tumor necrosis factor ligand superfamily member 13B antibody; B lymphocyte stimulator antibody; BLyS antibody; B-cell-activating factor antibody; BAFF antibody; Dendritic cell-derived TNF-like molecule antibody; TNF- and APOL-related leukocyte expressed ligand 1 antibody; TALL-1 antibody; CD antigen CD257) [Cleaved into: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form] antibody
Immunogen
Recombinant Human TNFSF13B protein
Immunogen Species
Homo sapiens (Human)
Concentration
It differs from different batches. Please contact us to confirm it.
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Notes
Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity > 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.
Usage
It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.